Amedisys [AMED] vs Encompass Health [EHC] Detailed Stock Comparison
Amedisys
NASDAQ
Loading...
Encompass Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Amedisys wins in 7 metrics, Encompass Health wins in 12 metrics, with 0 ties. Encompass Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Amedisys | Encompass Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 39.30 | 24.02 | Encompass Health |
| Price-to-Book Ratio | 2.69 | 5.45 | Amedisys |
| Debt-to-Equity Ratio | 35.34 | 86.97 | Amedisys |
| PEG Ratio | -2.78 | 0.97 | Amedisys |
| EV/EBITDA | 13.74 | 12.32 | Encompass Health |
| Profit Margin (TTM) | 3.56% | 9.22% | Encompass Health |
| Operating Margin (TTM) | 11.70% | 17.77% | Encompass Health |
| EBITDA Margin (TTM) | 11.70% | 17.77% | Encompass Health |
| Return on Equity | 6.67% | 24.72% | Encompass Health |
| Return on Assets (TTM) | 6.52% | 9.18% | Encompass Health |
| Free Cash Flow (TTM) | $214.29M | $360.30M | Encompass Health |
| Dividend Yield | N/A | 0.55% | N/A |
| 1-Year Return | 2.68% | 28.81% | Encompass Health |
| Price-to-Sales Ratio (TTM) | 1.38 | 2.19 | Amedisys |
| Enterprise Value | $3.48B | $15.81B | Encompass Health |
| EV/Revenue Ratio | 1.45 | 2.79 | Amedisys |
| Gross Profit Margin (TTM) | 43.96% | 43.01% | Amedisys |
| Revenue per Share (TTM) | $73 | $57 | Amedisys |
| Earnings per Share (Diluted) | $2.57 | $5.13 | Encompass Health |
| Beta (Stock Volatility) | 0.90 | 0.80 | Encompass Health |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Amedisys vs Encompass Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Amedisys | 0.00% | 0.05% | 3.57% | 7.76% | 9.12% | 11.10% |
| Encompass Health | 0.32% | -1.79% | -1.86% | 3.54% | 27.83% | 34.59% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Amedisys | 2.68% | -14.45% | -58.43% | 149.36% | 328.29% | 215.59% |
| Encompass Health | 28.81% | 162.80% | 128.33% | 299.42% | 754.91% | 663.56% |
News Based Sentiment: Amedisys vs Encompass Health
Amedisys
News sentiment data is not available for Amedisys at this time.
Encompass Health
News based Sentiment: POSITIVE
Encompass Health delivered a strong Q2 earnings report, received positive analyst coverage with increased price targets, and continues to execute its expansion strategy. While some insider selling and short-term stock declines occurred, the overall narrative is positive, indicating continued growth potential and investor confidence.
Performance & Financial Health Analysis: Amedisys vs Encompass Health
| Metric | AMED | EHC |
|---|---|---|
| Market Information | ||
| Market Cap | $3.32B | $12.63B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 1,027,642 | 581,540 |
| 90 Day Avg. Volume | 618,767 | 643,327 |
| Last Close | $100.99 | $123.62 |
| 52 Week Range | $82.15 - $101.02 | $87.85 - $127.86 |
| % from 52W High | -0.03% | -3.32% |
| All-Time High | $325.12 (Jan 25, 2021) | $127.86 (Sep 23, 2025) |
| % from All-Time High | -68.94% | -3.32% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.12% |
| Quarterly Earnings Growth | -0.13% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 0.09% |
| Operating Margin (TTM) | 0.12% | 0.18% |
| Return on Equity (TTM) | 0.07% | 0.25% |
| Debt to Equity (MRQ) | 35.34 | 86.97 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $37.48 | $22.60 |
| Cash per Share (MRQ) | $10.26 | $0.98 |
| Operating Cash Flow (TTM) | $239.42M | $1.11B |
| Levered Free Cash Flow (TTM) | $300.69M | $261.28M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.55% |
| Last 12-Month Dividend | N/A | $0.66 |
Valuation & Enterprise Metrics Analysis: Amedisys vs Encompass Health
| Metric | AMED | EHC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 39.30 | 24.02 |
| Forward P/E | 19.76 | 25.78 |
| PEG Ratio | -2.78 | 0.97 |
| Price to Sales (TTM) | 1.38 | 2.19 |
| Price to Book (MRQ) | 2.69 | 5.45 |
| Market Capitalization | ||
| Market Capitalization | $3.32B | $12.63B |
| Enterprise Value | $3.48B | $15.81B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.45 | 2.79 |
| Enterprise to EBITDA | 13.74 | 12.32 |
| Risk & Other Metrics | ||
| Beta | 0.90 | 0.80 |
| Book Value per Share (MRQ) | $37.48 | $22.60 |
Financial Statements Comparison: Amedisys vs Encompass Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AMED | EHC |
|---|---|---|
| Revenue/Sales | $621.86M | $1.46B |
| Cost of Goods Sold | $348.47M | $824.50M |
| Gross Profit | $273.39M | $630.90M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $72.74M | $267.00M |
| EBITDA | $97.35M | $349.60M |
| Pre-Tax Income | $48.33M | $238.60M |
| Income Tax | $19.27M | $41.60M |
| Net Income (Profit) | $29.05M | $196.50M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AMED | EHC |
|---|---|---|
| Cash & Equivalents | $337.30M | $95.80M |
| Total Current Assets | $662.20M | $910.90M |
| Total Current Liabilities | $488.36M | $856.00M |
| Long-Term Debt | $386.83M | $2.54B |
| Total Shareholders Equity | $1.27B | $2.94B |
| Retained Earnings | $880.25M | $930.80M |
| Property, Plant & Equipment | $229.50M | $3.94B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AMED | EHC |
|---|---|---|
| Operating Cash Flow | $75.50M | $289.30M |
| Capital Expenditures | $-696,000 | $-163.10M |
| Free Cash Flow | $66.29M | $125.50M |
| Debt Repayment | N/A | $-80.00M |
| Common Stock Repurchase | N/A | $-32.10M |
Short Interest & Institutional Ownership Analysis
| Metric | AMED | EHC |
|---|---|---|
| Shares Short | 3.20M | 1.46M |
| Short Ratio | 6.84 | 2.25 |
| Short % of Float | 0.10% | 0.02% |
| Average Daily Volume (10 Day) | 1,027,642 | 581,540 |
| Average Daily Volume (90 Day) | 618,767 | 643,327 |
| Shares Outstanding | 32.78M | 100.78M |
| Float Shares | 32.24M | 99.22M |
| % Held by Insiders | 0.02% | 0.01% |
| % Held by Institutions | 0.96% | 0.97% |
Dividend Analysis & Yield Comparison: Amedisys vs Encompass Health
| Metric | AMED | EHC |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.66 |
| Last 12-Month Dividend Yield | N/A | 0.55% |
| 3-Year Avg Annual Dividend | N/A | $3.68 |
| 3-Year Avg Dividend Yield | N/A | 1.66% |
| 3-Year Total Dividends | N/A | $11.04 |
| Ex-Dividend Date | N/A | Apr 01, 2025 |